1287 related articles for article (PubMed ID: 19719418)
1. What is inadequate antibacterial therapy?
Moellering RC
Clin Infect Dis; 2009 Oct; 49(7):1006-8. PubMed ID: 19719418
[No Abstract] [Full Text] [Related]
2. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
[No Abstract] [Full Text] [Related]
3. [Monitoring of antibacterial therapy].
Dzierzanowska D
Przegl Lek; 1984; 41(2):247-51. PubMed ID: 6739843
[No Abstract] [Full Text] [Related]
4. Antimicrobial resistance: action by laboratories today for a cure tomorrow.
Kanungo R
Indian J Med Microbiol; 2011; 29(3):205-6. PubMed ID: 21860096
[No Abstract] [Full Text] [Related]
5. A rational approach to the selection of an antimicrobial agent.
Hirsh DC; Ruehl WW
J Am Vet Med Assoc; 1984 Nov; 185(10):1058-61. PubMed ID: 6392230
[No Abstract] [Full Text] [Related]
6. [Infections through gram positive bacteria].
Mendoza-Hernández P
Gac Med Mex; 1975 Jul; 110(1):70-4. PubMed ID: 1149997
[No Abstract] [Full Text] [Related]
7. Whither antibacterial drug discovery?
Projan SJ
Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
[No Abstract] [Full Text] [Related]
8. [Infections through gram-negative bacteria].
Ruiloba J
Gac Med Mex; 1975 Jul; 110(1):66-9. PubMed ID: 1149996
[No Abstract] [Full Text] [Related]
9. Methodology of prevention of antibiotic resistance.
Shetty A
J Assoc Physicians India; 2010 Dec; 58 Suppl():47-8. PubMed ID: 21568010
[No Abstract] [Full Text] [Related]
10. Antibiotics of choice for clinically important bacteria.
Jeljaszewicz J
Adv Clin Pharmacol; 1974; 8():89-95. PubMed ID: 4468734
[No Abstract] [Full Text] [Related]
11. Therapy of patients with resistant bacterial infections.
Rahal JJ
Bull N Y Acad Med; 1987 Apr; 63(3):318-29. PubMed ID: 3300830
[No Abstract] [Full Text] [Related]
12. [Tolerance to antibacterial agents: current focus and trend of research].
Wang H; Chen HB
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1369-71. PubMed ID: 18953871
[No Abstract] [Full Text] [Related]
13. Late stage antibacterial drugs in the clinical pipeline.
Projan SJ; Bradford PA
Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
[TBL] [Abstract][Full Text] [Related]
14. Multi-targeting by monotherapeutic antibacterials.
Silver LL
Nat Rev Drug Discov; 2007 Jan; 6(1):41-55. PubMed ID: 17159922
[TBL] [Abstract][Full Text] [Related]
15. The bacteria fight back.
Taubes G
Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
[No Abstract] [Full Text] [Related]
16. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
[TBL] [Abstract][Full Text] [Related]
17. Doripenem: an early look at a carbapenem not yet approved for pediatrics.
Overturf GD
Pediatr Infect Dis J; 2010 Feb; 29(2):163-5. PubMed ID: 20135831
[No Abstract] [Full Text] [Related]
18. [Bacterial susceptibility to chemotherapeutic agents (Zurich, 1987)].
Wüst J; Kayser FH
Schweiz Rundsch Med Prax; 1989 Jun; 78(26):745-50. PubMed ID: 2756266
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial susceptibility testing in the clinical laboratory.
Holland TL; Woods CW; Joyce M
Infect Dis Clin North Am; 2009 Dec; 23(4):757-90, vii. PubMed ID: 19909884
[TBL] [Abstract][Full Text] [Related]
20. [Treatment with antibacterial chemotherapy].
Schauer J; Tauchnitz C
Z Gesamte Inn Med; 1992 Sep; 47(9):386-90. PubMed ID: 1441664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
